Featured Articles

  1. Inside Interius' Global Regulatory Strategy 12/13/2024

    Interius BioTherapeutics' lentiviral gene therapy INT2104, which creates CAR T and CAR NK cells in vivo, headed to clinical trials in Australia where the company dosed a first patient with a B-cell malignancy. CEO Phil Johnson, M.D. gave us a look inside the company's global regulatory strategy.

  2. The Bond Factor: Connecting For Success In Life Sciences 12/13/2024

    Sanofi’s chief learning officer Wanda Shoer explains the importance of self-awareness about of your own core skills, talents, and values in becoming more adaptable and successful. 

  3. Optimism For Life Sciences Growth Amid Policy Shifts In 2025 12/11/2024

    EY's Arda Ural provides an assessment of the current life sciences business environment, and reasons for optimism about 2025 despite the uncertainty that comes with a new administration in the U.S.

  4. Leading Through Biotech's Perfect Storm: Lessons From The Front Lines 12/9/2024

    Memo Therapeutics CEO Erik van den Berg reflects on the strategies and skills needed to build company resilience and navigate successfully through challenging external circumstances.

  5. Four Ways For Legal Departments To Create Financial Efficiency 12/6/2024

    Life sciences legal departments can do more to improve financial efficiency across an organization. This article includes insights from an Ernst & Young survey of multinational corporations across the pharmaceutical, consumer health, and medical device industries.

  6. The Fork In The Road: Personal Decisions That Change Our Career Trajectory 12/4/2024

    Novo Nordisk SVP Blandine Lacroix shares her career story and discusses the importance of prioritizing your own personal needs, and the personal needs of others, in navigating a professional career.

  7. FDA's Psychedelic Reckoning 11/27/2024

    Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits of FDA breakthrough therapy designation, and talks about why RFK Jr. as HHS Secretary could be a win for psychedelic drug developers.

  8. How To Lead a Company That's Disrupting An Industry 11/22/2024

    Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.

  9. Translating Hidden Gems Into Medicines 11/19/2024

    Reflecting on 20 years of experience working as a scientist in Big Pharma and biotech, Louise Modis, Ph.D., CSO at Amphista Therapeutics, shares the key elements necessary for successful drug discovery and development.

  10. CEO Panel Talks IRA Impact At Galien Forum 11/14/2024

    A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far, and what's likely to come in the year ahead.